1. Introduction {#s1}
===============

The haematocrit in neonates fluctuates with gestational and postnatal age; with the advance of gestation the mean haematocrit level progressively increases, and in the first 28 days after birth a more or less linear decrease in haematocrit occurs ([@ref17]). The haematocrit concentration of preterm born neonates declines for an even longer period after birth (8--12 weeks) and has a lower nadir compared to the physiologic anaemia of term newborns ([@ref28]). This is caused by a rapid body growth resulting in haemodilution, a shorter lifespan of the red blood cells, poor iron stores and the liver being the primary source of erythropoietin production initially ([@ref32]). In addition, the haematocrit in neonates is known to have a wider variability (28--67%) ([@ref4]; [@ref10]) compared to the haematocrit in adult subjects (38--46%) ([@ref3]). The spin-lattice or longitudinal relaxation time of blood (*T*~1b~) is linearly dependent on haematocrit due to the fast exchange regime of water protons between the blood cell and plasma compartment of blood. In-vitro measurements, performed on bovine blood, confirmed the linear dependency of the venous *T*~1b~ on haematocrit (1/*T*~1b~ = 0.83 × Hct + 0.28), and this within a normal haematocrit range of 0.38--0.46 ([@ref20]). Based on these data and assuming an average haematocrit value of 0.42, the *T*~1b~ is commonly assumed to be 1.6 s ([@ref11]; [@ref24]). However, recent in vivo studies performed in adult subjects found longer *T*~1b~; 1.85 s ([@ref31]) and 1.78 s ([@ref33]), possibly due to higher methaemoglobin levels in 'in vitro' blood samples ([@ref9]). Similar higher values (1.80 s) were found by Varela et al. (in the neonatal population, although with a wider range (1.40--2.00 s) which is thought to be caused by the larger spread in haematocrit ([@ref35]). In this specific population, a linear relationship between the venous *T*~1b~ and haematocrit has been demonstrated as well under the form of 1/*T*~1b~ = 0.50 × Hct + 0.37. The *T*~1b~ is an important parameter in black-blood angiography ([@ref6]), the vascular space occupancy technique ([@ref21]) and arterial spin labelling MRI ([@ref36]). Therefore, errors in the *T*~1b~ estimate may have important implications regarding image quality and accuracy of the methods. An accurate estimate of the *T*~1b~ may be obtained by *T*~1b~-mapping ([@ref31]; [@ref35]; [@ref38]). Because blood *T*~1~ sequences and their postprocessing tools are not readily available on most MR platforms, a good alternative would be to estimate the *T*~1b~ from haematocrit ([@ref20]; [@ref33]; [@ref35]). The existing relationships between the *T*~1b~ and neonatal haematocrit are obtained from experiments in which the haematocrit values were determined with either a spinning or a sedimentation technique ([@ref35]). However, in clinical practice, a point-of-care test (POCT), which deduces haematocrit from for instance conductivity measurements, is commonly used to determine the haematocrit in neonates. This technique is known to introduce errors in haematocrit measurements as its accuracy is dependent on the preanalytical and analytical steps; a delay in testing, total protein and lipid levels, sodium concentration and erythroblasts may influence the haematocrit estimate ([@ref1]). Neonates are known to have lower protein content compared to adults ([@ref8]) which may artificially decrease haematocrit estimate ([@ref1]), total parenteral nutrition can induce hyperlipidaemia ([@ref30]) which can lead to an overestimation of the haematocrit ([@ref1]), and one study found an overestimation of the haematocrit count with a POCT which was explained by the interference of erythroblasts ([@ref29]). Therefore, it is sensible to evaluate the relation between POCT-obtained haematocrit and the *T*~1b~ before estimating the *T*~1b~ from haematocrit using previous established relations.

The purpose of this study is therefore twofold. First, to evaluate the *T*~1b~ in neonates, at the same time investigating its impact on quantitative arterial spin labelling perfusion estimates. Second, to evaluate if the established relationships between haematocrit and *T*~1b~ also hold true for the more commonly available capillary-drawn or arterial-drawn point-of-care estimates of haematocrit.

2. Materials and methods {#s2}
========================

2.1. Subjects {#s2.1}
-------------

The ethics committee of our institution approved this retrospective study and waived the requirement to obtain written parental informed consent. Neonates with MR imaging between September 2011 and December 2013 were included. Of the 104 neonates 51 neonates were male and 53 neonates were female. In 16 of the 104 neonates (8 males, 8 females) follow-up MR imaging was performed. Data of all 120 MR scans were used for data analysis. The mean age of the study subjects at the time of MR imaging was 40 weeks postconceptional age (range = 30--54 weeks). In our institution, preterm born infants are imaged at preterm age and at term-equivalent age for research purposes. Therefore, subjects were categorized into the following categories. 1) Preterm: neonates with MR imaging at preterm age. 2) TEA: preterm born neonates with MR imaging at term-equivalent age. 3) Diseased: neonates with a clinical indication for MR imaging. In the latter category, 27 infants were diagnosed with perinatal asphyxia, 14 infants were suspected for stroke or MR imaging was performed for follow-up after stroke, 4 infants were imaged after surgery to evaluate white matter damage, 3 infants were suspected for haemorrhage on ultrasound images or MRI was performed for follow-up after haemorrhage, 2 infants had a viral infection with neurological symptoms, and 1 infant with a developmental venous anomaly and 1 infant with a twin-to-twin transfusion syndrome were imaged. Mean (range) postconceptional age at birth, mean (range) postnatal age at the time of MR imaging, gender and the breathing condition are shown for each category in [Table 1](#tbl1){ref-type="table"}.

2.2. Laboratory analysis {#s2.2}
------------------------

Haematocrit (Hct) was measured using a point-of-care device in 66 infants (16 preterms, 13 TEA and 37 diseased) within 24 h of MR imaging, 46 blood samples were capillary-drawn (Hct~cd~) and 20 arterial-drawn (Hct~ad~). For this, a test cartridge blood analysis system (Abbott i-STAT System, Abbott Laboratories, Abbott Point of Care Inc., Princeton, New Jersey) was used. This system consists of microfabricated sensors housed in a cartridge which measure the conductivity. The measured conductivity, after correction for electrolyte concentration, is inversely related to the haematocrit. Estimates of imprecision for this device, performed on adult blood and evaluated against other point-of-care tests using either conductivity or optical technology, ranged from 0.46% to 1.31%, and a test--retest study found a coefficient of variation of 1.5% ([@ref1]). For our measurements, capillary-drawn blood was collected by pricking the skin of the infants\' heel and arterial-drawn blood was collected via an umbilical line or through a line in the radial artery. During blood collection, the infants were in supine position.

2.3. Image acquisition {#s2.3}
----------------------

All MRI studies were performed on a 3.0 Tesla Philips Achieva System (Philips Medical Systems, Best, The Netherlands). Images were acquired using the quadrature body coil for transmission. An 8-element phased-array head coil was used as a signal receiver. In neonates imaged at preterm age a 4-element flex coil was used (SENSE Flex L + S) as signal receiver. A neonatologist was present throughout the entire examination. Monitoring of heart rate, respiratory rate (Philips, Best, The Netherlands) and transcutaneous oxygen saturation (Nonin Pulse Oxymetry, Nonin Medical, Plymouth, MN) was performed during MR imaging. In infants with artificial breathing support, the ventilation pressure was set to maintain a stable oxygen saturation of 90--95% in preterm infants and 95--100% in infants imaged at term-equivalent age. Prior to MR imaging neonates were sedated; chloral hydrate was administered orally (50--60 ml/kg), in neonates scanned around 3-months equivalent age an intramuscular injection of pethidine, chlorpromazine and promethazine was used. In order to minimize motion-related artefacts neonates were wrapped into an MR-compatible vacuum cushion. For hearing protection MiniMuffs (Natus Europe, Münich, Germany) and earmuffs (EM\'s 4 Kids, Everton Park, Australia) were used. In addition to the conventional MR imaging scan protocol a localizer MR angiography slab, a *T*~1~ inversion recovery sequence ([@ref35]) and pulsed ASL perfusion imaging were performed. The *T*~1~ inversion recovery sequence consisted of a single adiabatic inversion pulse followed by a single-shot echo-planar imaging as readout ([@ref35]). The adiabatic inversion pulse was preceded by a presaturation pulse ([Fig. 1a](#gr1){ref-type="fig"}). Scan parameters were; TR/TE/ΔTI/*TI*~1~: 15 s/20 ms/140 ms/20 ms, 50 phases, scan matrix 128 × 128, FOV 160 × 160, flip angle 95°, slice thickness 3 mm and SENSE 2.5. The imaging plane of the *T*~1~ inversion recovery sequence was positioned perpendicular to the superior sagittal sinus based on the sagittal angiography image. Arterial spin labelling MR imaging consisted of a pulsed star labelling of arterial regions (PULSAR) pulse sequence ([@ref12]) followed by a multi-slice, single-shot echo-planar imaging readout. Scan parameters of the ASL sequence were: matrix 40 × 40, FOV 160 × 128 mm, SENSE 2.5, voxel size 4 × 4 × 7 mm, gap between slices 1 mm, TR/TE: 2700/17 ms, flip angle 90°, inversion delay (*TI*~2~) 1500 ms, 70 averages, labelling slab 10 cm, gap between imaging plane and labelling plane 1 cm, no vascular crushers and scan time 3:20 min. To obtain a finite bolus length a saturation pulse was applied in the labelling region 600 ms (*TI*~1~ = 600 ms) after the labelling pulse using the Q~2~TIPS technique ([@ref23]). Eleven slices were acquired in ascending slice order. Planning of the imaging plane was performed based on sagittal *T*~1~-weighted images.

2.4. Image analysis {#s2.4}
-------------------

Images were analysed using IDL 6.1 for Windows (ITT Visual Information Solutions, Boulder, CO, U.S.A.). The *T*~1b~ was estimated from the *T*~1~ inversion recovery data. First, automatic localization of the sagittal sinus was performed on the magnitude reconstructed data; at later time points, the inflowing blood signal is high (fully recovered) while the surrounding 'static' tissue is suppressed by the repeated acquisition at high flip angle ([Fig. 1c](#gr1){ref-type="fig"}). This allows for automatic detection of the sagittal sinus by searching for the largest connected high intensity region in the posterior region. The combination of voxels which resulted in the smallest overall residual error of the fit was subsequently chosen from within the initial region-of-interest ([Fig. 1b](#gr1){ref-type="fig"}). This selection was based on the goodness of fit of the individual voxels within the region of interest where the best fits were incrementally averaged until the overall residual errors reached a minimum. These voxels were then averaged and used for the subsequent analysis. The *T*~1b~ was derived from the inversion recovery curve using a standard two parameter inversion recovery model ([@ref35]):$$S\left( t \right) = M_{0}\left( 1 - {2\text{e}}^{- \frac{t}{T_{1}}} \right)$$

where *S*(*t*) is the signal over time, *M*~0~ is the magnetization, *t* is the time and *T*~1~ is the longitudinal relaxation of blood.

Data obtained during ASL imaging were processed as follows. First, ASL images were motion corrected using a two-step approach. A 6 parameter affine transformation between (control-label) image pairs was applied, followed by a 12 parameter affine transformation to get all control-label volume pairs aligned. Subsequently, the ASL imaging pairs were subtracted to generate Δ*M* images. The mean and standard deviation of the difference signal over the subtracted image pairs were calculated and image pairs with a difference signal larger than 2 standard deviations of the mean were automatically discarded ([@ref26]). The remaining Δ*M* images were averaged to create Δ*M*~total~ images and CBF was quantified ([Fig. 1d](#gr1){ref-type="fig"}) using the following formula ([@ref2]; [@ref23]):$$f = \frac{\text{λ}\text{Δ}M}{2\text{α}M_{0t}TI_{1}\text{e}^{\frac{- TI_{2}}{T_{1b}}}}$$

with *f* the cerebral blood flow, λ the brain--blood partition coefficient, Δ*M* the total magnetization difference between control and label images, α the inversion efficiency, *M*~0*t*~ the tissue magnetization, *TI*~1~ the bolus length (600 ms), *TI*~2~ the inversion delay (1500 ms) and *T*~1b~ the longitudinal relaxation time of blood. The α and the λ were assumed to be 95% and 1.1 ml/g ([@ref14]), respectively, the latter represents an average whole-brain neonatal λ value. The *T*~1b~ was set at 1.6 s based on a recent ASL study in neonates ([@ref24]) although most earlier studies use an even shorter *T*~1b~ of typically 1.5 s ([@ref25]; [@ref37]). Whole brain CBF values were obtained and called (CBF~1.6~). Hereafter, CBF was quantified with the *T*~1b~ derived from the inversion recovery sequence (CBF~cor~, corrected CBF) and with the mean *T*~1b~ found in our study population (CBF~mean~).

2.5. Data analysis {#s2.5}
------------------

IBM SPSS Statistics (version 19.0.1, SPSS Inc., Chicago, IL) was used for statistical analysis. For all analyses, a *p*-value lower than 0.05 was considered statistically significant. For the *T*~1b~ fitting, a 95% confidence interval of the final fitted *T*~1b~ was estimated based on a bootstrap resampling of the fitting residuals ([@ref7]). This confidence interval was expressed as percentage of the individual\'s mean *T*~1b~ and the average interval was calculated for the entire group as well as for each category. Mean *T*~1b~, standard deviation and range were calculated for all neonates and within each category of neonates. An independent sample *t*-test was used to compare the *T*~1b~ in ventilated infants to the *T*~1b~ in infants who were not ventilated and to compare the *T*~1b~ between the preterm and the TEA. In the infants with both MR imaging at preterm age and at TEA, a paired sample *t*-test was used to compare the *T*~1b~ at preterm to the *T*~1b~ at TEA. Likewise, a paired sample *t*-test was used to compare CBF~1.6~ to CBF~cor~ for all infants and for the infants with longitudinal data. The normalized perfusion difference (NPD) was calculated: NPD = ((CBF~cor~ − CBF~1.6~) / CBF~1.6~) × 100. A one-sample *t*-test was used to test the null hypothesis; "the normalized perfusion difference equals zero". Similarly, we calculated the normalized perfusion difference when going from CBF quantified with the mean *T*~1b~ found in this study (CBF~mean~) to CBF quantified with the individual-derived *T*~1b~ (CBF~cor~); NPD = ((CBF~cor~ − CBF~mean~) / CBF~mean~) × 100. An independent sample *t*-test was used to compare the mean normalized perfusion difference (CBF~cor~ versus CBF~1.6~) between preterm and TEA and to investigate if the increase in perfusion from preterm to TEA was significant. In infants with both haematocrit and *T*~1b~ we investigated the relation between R~1b~ (1/*T*~1b~) and haematocrit by means of linear regression analysis. The coefficients of determination (*R*^2^) were calculated to evaluate the fit of the models. In those infants, the haematocrit at preterm age was compared to the haematocrit at TEA using an independent sample *t*-test.

2.6. Simulations {#s2.6}
----------------

As the *T*~1b~ is known to depend not only on the haematocrit but also on the oxygenation level of blood ([@ref20]; [@ref34]), errors may occur in the *T*~1b~--haematocrit relationship due to not measuring the *T*~1b~ in fully oxygenated blood. In order to evaluate this error a simulation was performed based on evidence from the existing literature. The dependence of the *T*~1b~ as a function of haematocrit (Hct) and oxygen saturation (Y) has been shown to have the form ([@ref13]):$$T_{1\text{b}}\left( \text{Hct},\text{Y} \right) = \frac{1}{\left( F_{\text{ery,w}}\left( \text{Hct} \right) \cdot \left( \text{A} + \text{B} \cdot \left( 1 - \text{Y} \right) \right)\quad + \quad\left( 1 - F_{\text{ery,w}}\left( \text{Hct} \right) \right) \cdot \text{C} \right)}$$

where *T*~1b~(Hct, Y) is the longitudinal relaxation time of blood as a function of haematocrit and oxygenation and *F*~ery,w~(Hct) is the fraction of water in the whole blood that resides inside erythrocytes as a function of haematocrit (Eq. (3) in [@ref13]). Solving this equation with data presented at 3 T ([@ref20]) results in A = 0.97 s^−1^, B = 0.52 s^−1^ and C = 0.36 s^−1^ which was used to assess the possible error in the *T*~1b~--Hct relationship as a result of not measuring the *T*~1b~ in fully oxygenated blood.

In this paper, the normalized perfusion difference was evaluated based on the effect of haematocrit on the *T*~1b~ ([@ref20]; [@ref35]). However, λ in [Eq. (2](#eqn2){ref-type="disp-formula"}) is also known to be haematocrit dependent with an opposite effect than the *T*~1b~ and therefore also affects the normalized perfusion difference. In order to investigate the overall normalized perfusion difference a simulation was performed. For this, λ--Hct relationships obtained from the literature ([@ref14]) were used together with the established *T*~1b~--Hct relationship obtained in this study and results of this were compared against a constant *T*~1b~ and a constant λ (1.1 ml/g).

3. Results {#s3}
==========

The *T*~1b~ could be derived from the inversion recovery curve in 82 out of 120 MR imaging sessions (68%). In these, the mean (standard deviation, sd) number of voxels selected by the automatic localizer was 5 (3). Mean *T*~1b~ was 1.85 (0.2) s and ranged from 1.4 s to 2.3 s. The average 95% confidence interval of the *T*~1b~ fitting was \[−2.26%, 2.31%\]. No significant difference was found in the *T*~1b~ of ventilated infants (*n* = 18, *T*~1b~ is 1.78 (0.19)) versus the *T*~1b~ of infants who were not ventilated (*n* = 64, *T*~1b~ is 1.87 (0.21)). Mean *T*~1b~ in the preterm was 1.77 (0.14) s, 1.89 (0.19) s in the TEA, and 1.81 (0.24) s in the diseased. These values, the ranges and the 95% confidence interval of the *T*~1b~ fitting are shown in [Table 2](#tbl2){ref-type="table"}. [Fig. 2a](#gr2){ref-type="fig"} shows median, interquartile distance, minimum and maximum *T*~1b~ values for each category in a boxplot. The *T*~1b~ was significantly different in the preterm than in the TEA (*p* \< 0.05). In 6 (out of 8) infants with MR imaging at preterm and at TEA the *T*~1b~ could be derived from the inversion recovery sequence at both time points. The mean postconceptional age at preterm in these infants was 30 (1) weeks and the mean *T*~1b~ at preterm age was 1.76 (0.17) s. The mean postconceptional age at TEA in these 6 infants was 41 (1) weeks and the mean *T*~1b~ was 1.99 (0.13) s. In these 6 infants, the *T*~1b~ at preterm was significantly different from the *T*~1b~ at TEA (*p* \< 0.05). The mean postnatal age of all the infants was 49 (42) days and ranged from 1 to 119 days. The relation between *T*~1b~ and postnatal age (PNA, in days) is shown in [Fig. 2b](#gr2){ref-type="fig"}. In this figure each colour represents a category of infants.

In 76 of the 82 infants in whom the *T*~1b~ was derived from the inversion recovery sequence, whole brain CBF was evaluated. For this analysis, an average of 10.5 (3)% of the ASL images was automatically discarded due to motion artefacts. Mean CBF~1.6~ was 17.3 (10.9) ml/100 g/min and CBF~cor~ was 14.5 (10.4) ml/100 g/min. These were significantly different (*p* \< 0.001). The mean normalized perfusion difference was −11 (9.1)% and the difference ranged from −27.3% to 13.5% (*p* \< 0.001). As the mean *T*~1b~ found in this study was 1.85 s, we quantified CBF with a *T*~1b~ of 1.85 s and calculated the normalized perfusion difference when going from CBF~1.85~ (=CBF~mean~) to CBF~cor~. The mean normalized perfusion difference was 2 (10.4)% and the difference ranged from −16.8% to 29.9%. For each category of infants (preterms, TEA and diseased) the CBF values (CBF~1.6~, CBF~cor~ and CBF~1.85~) and their corresponding normalized perfusion differences are shown in [Table 3](#tbl3){ref-type="table"}, the mean postconceptional age at the time of MRI with ASL whole brain CBF values was 31 (2) weeks for the preterms, 41 (1) weeks for the TEA and 43 (6) weeks for the diseased infants. The normalized perfusion difference, when going from CBF~1.6~ to CBF~cor~, was significantly different in all preterm than in all the TEA infants (*p* \< 0.05). The maturational increase in perfusion was 195% on the CBF~1.6~ images (*p* \< 0.01) compared to 178% on the CBF~cor~ images (*p* \< 0.01). Of the 6 infants with MRI *T*~1b~ data at preterm and term-equivalent age whole brain CBF was evaluated at both time points in 4 infants. In these 4 infants, the normalized perfusion difference, when going from CBF~1.6~ to CBF~cor~, was −4.1 (11.8)% at preterm age and −18.5 (3.8)% at term-equivalent age, this did not reach significance (*p* = 0.051). The maturational increase in perfusion of these 4 infants was 167% on the CBF~1.6~ images compared to 135% on the CBF~cor~ images.

In 39 neonates both haematocrit and *T*~1b~ were available; in 10 preterms mean haematocrit was 0.4 (0.04), in 12 TEA infants it was 0.34 (0.06) and in 17 diseased infants mean haematocrit was 0.46 (0.07). The haematocrit in the preterms was significantly different from the haematocrit in the TEA (*p* \< 0.01). The relation between R~1b~ and haematocrit was investigated and was generally moderate: R~1b~ = 0.38 \[0.16--0.61\] × Hct + 0.41 \[0.31--0.50\] (*N* = 39, *R*^2^ = 0.25, *p* \< 0.001), with the 95% confidence interval shown between brackets. The haematocrit data was further subdivided into capillary-drawn (*n* = 29) and arterial-drawn (*n* = 10) haematocrit. Capillary-drawn haematocrit was obtained from 9 preterm, 12 TEA and 8 diseased neonates. Arterial-drawn haematocrit was obtained from 1 preterm and 9 diseased neonates. The relation between R~1b~ and arterial-drawn haematocrit was R~1b~ = 0.80 \[0.39--1.22\]·Hct~ad~ + 0.22 \[0.03--0.40\] (*R*^2^ = 0.71, *p* \< 0.01). This was stronger than the relation between R~1b~ and capillary-drawn haematocrit: R~1b~ = 0.25 \[−0.02--0.51\]·Hct~cd~ + 0.46 \[0.35--0.57\] (*R*^2^ = 0.12, *p* = 0.69). In [Fig. 3](#gr3){ref-type="fig"}, the relation between haematocrit and MRI-derived *T*~1b~ is shown. The relation between R~1b~ and haematocrit was investigated both for ventilated infants and for the infants who were not ventilated. For the ventilated infants (*n* = 17) the relation was; R~1b~ = 0.41 \[−0.35--0.85\] × Hct + 0.40 \[0.21--0.59\], *R*^2^ = 0.21. For the nonventilated infants (*n* = 22) the relation was R~1b~ = 0.36 \[0.07--0.66\] × Hct + 0.41 \[0.29--0.53\], *R*^2^ = 0.25, *p* \< 0.05.

A simulation of the dependence of the *T*~1b~ on haematocrit and oxygenation (Y) is shown in [Fig. 4a](#gr4){ref-type="fig"}. In this figure the variation in the *T*~1b~ for different haematocrit values and oxygenation levels is shown. This figure demonstrates that for a similar haematocrit value *T*~1b~ is expected to change around 200 ms when going from a low venous oxygenation level of 40% to an arterial oxygenation level of close to 100%. A second simulation ([Fig. 4b](#gr4){ref-type="fig"}) demonstrates the normalized perfusion difference introduced by the influence of haematocrit on the *T*~1b~, this with and without taking the influence of haematocrit on the brain--blood partition coefficient (λ) into account. From this figure it can be inferred that the normalized perfusion difference increases with up to 5--10% at low and high Hct values when λ is corrected for haematocrit. There is limited effect of λ on the normalized perfusion difference at haematocrit levels around 0.4--0.45. In other words, by keeping the λ constant has a small compensatory effect on the CBF error.

4. Discussion {#s4}
=============

We evaluated the *T*~1~ of blood in neonates and found a mean *T*~1b~ of 1.85 s which is higher than the commonly assumed ≤1.6 s. As expected, a wide variability in the *T*~1b~, from 1.4 s to 2.3 s, was observed. So far the *T*~1b~ was only evaluated in 18 neonates where a similar wide variability was demonstrated ([@ref35]). What our study adds to the previous one is the evaluation of the *T*~1b~ in categories of neonates. We found that the *T*~1b~ in preterm born infants was significantly different from the *T*~1b~ in preterm born infants imaged at term-equivalent age. This corresponded to the differences that we found in haematocrit, preterms had a haematocrit of 0.40 while the preterm born infants at term-equivalent age had a haematocrit of 0.34. Similar results were found in the infants with longitudinal data. Although the decline in haematocrit after birth may support a postnatal age-dependent *T*~1b~, it is important to realize that the decline in haematocrit in term born neonates after birth has a shorter time-span compared to the decline in preterms, haematocrit levels restore 4--6 weeks after birth in term neonates ([@ref28]). In addition, even within the preterms and the TEA infants the *T*~1b~ range was wide and overlapping, and a plot demonstrating the relation between the *T*~1b~ and postnatal age showed a wide variability ([Fig. 2b](#gr2){ref-type="fig"}).

The *T*~1b~ is an important parameter in a range of imaging modalities. Because ASL MR imaging is part of our imaging protocol we used it to demonstrate the importance of estimating the *T*~1b~ in neonates as it is a parameter needed for quantification. The mean normalized perfusion difference when quantifying CBF with a *T*~1b~ of 1.6 s as opposed to the corrected *T*~1b~ value was −11%. Furthermore, we demonstrated that the maturational increase in perfusion is overestimated when quantifying CBF with a fixed *T*~1b~ of 1.6 s. A similar overestimation of the maturational increase in perfusion was found in 4 infants with serial MR imaging at preterm and term-equivalent age. In this study we choose a *T*~1b~ of 1.6 s as the reference value as this was used in a recent neonatal ASL study ([@ref24]). However, values of 1.5 s have also been reported ([@ref25]; [@ref37]) and would make the normalized perfusion difference even larger. Our findings clearly demonstrate that the *T*~1b~ should be corrected when performing *T*~1b~-dependent MRI studies in neonates and that it is in particular important when the studies are of longitudinal origin. Although we demonstrated that a more appropriate neonatal *T*~1b~ probably resides around 1.85 s, adopting this value in ASL studies would only shift the global mean of neonatal CBF but it would not account for the variations due to e.g. postnatal age. Applying the group mean *T*~1b~ of 1.85 s obtained in this study instead of an individual-obtained *T*~1b~ eliminated the average normalized perfusion difference while the range still remained wide (−16.8% to +29.9%). As is shown in [Fig. 2](#gr2){ref-type="fig"}, there is a large spread of *T*~1b~ (and Hct) within each group and even when applying an individual-obtained *T*~1b~ the spread in the CBF estimates remains in the same range within the groups ([Table 3](#tbl3){ref-type="table"}). Important for the reader to note is that not only the *T*~1b~ but also the brain--blood partition coefficient (λ) is dependent on haematocrit ([@ref14]). This was not taken into account when calculating the normalized perfusion difference. However, λ is linearly related to cerebral blood flow whereas *T*~1b~ has an exponential relation and thus the effect of λ on the normalized perfusion difference is less. This was demonstrated by a simulation which showed that the effect of haematocrit on λ may increase the normalized perfusion difference with another 5%.

Blood *T*~1~ sequences and their postprocessing tools are not readily available on most MR platforms. Therefore, a good alternative would be to estimate *T*~1b~ from haematocrit which in most cases is available around the time of MR imaging. In order to test the reliability of the earlier established relationships between the *T*~1b~ and haematocrit when using a point-of-care device to measure haematocrit, we analysed the relation between haematocrit, determined by means of a conductivity-based point-of-care device, and the *T*~1b~. Contrary to the earlier studies in which a sedimentation or spinning technique was used ([@ref20]; [@ref35]), we found only a moderate relation (*R*^2^ = 0.249, *p* \< 0.01, R~1b~ = 0.38 × Hct + 0.40). This relation did fall within the 95%-confidence interval of the relation previously found by Varela et al.; R~1b~ = 0.5 × Hct + 0.37 ([@ref35]). We know that the haematocrit is by itself susceptible to noise as posture ([@ref16]), punctuate location and sample (arterial-drawn, capillary-drawn or venous-drawn sample) ([@ref18]; [@ref27]) can influence its results. Therefore, we subdivided the samples into arterial-drawn and capillary-drawn and interestingly enough we discovered a strong relation with arterial-drawn haematocrit (*R*^2^ = 0.711, *p* \< 0.01) but a weak and nonsignificant relation between capillary-drawn haematocrit and *T*~1b~. There could be several reasons for the lack of correlation in the capillary-drawn samples. First, the infants in whom the capillary measurements were performed might have had less reliable *T*~1b~ measurements, in fact there were more preterms and TEA present in the capillary-drawn group than in the group with arterial samples and we found a broader 95% confidence interval of the *T*~1b~ fitting in the preterms compared to the other categories. Another plausible cause could be that the infants in whom the capillary measurements were performed might have had a larger spread of the venous oxygenation. In fact, more preterms were ventilated and we found the relation between R~1~ of blood and haematocrit to be nonsignificant in the ventilated infants suggesting an influence of oxygenation on the *T*~1b~--haematocrit relation. The *T*~1b~ is known to be related to both haematocrit and oxygenation ([@ref13]) and therefore to give some insight into the potential errors due to the oxygenation status on the *T*~1b~ estimate, simulations are shown in [Fig. 3a](#gr3){ref-type="fig"}. This figure demonstrates that a realistic fluctuation of ˜20% in venous oxygenation may give rise to a 100 ms difference in *T*~1b~. This would translate into an error of ±0.1 in the haematocrit, at most. While there might be errors in the *T*~1b~ estimate related to the population bias of the neonates with capillary-drawn Hct, we still speculate that the main reason for this weak Hct--*T*~1b~ relationship is due to uncertainties in the actual measured capillary haematocrit. The arterial-drawn *T*~1b~--Hct relationship on the other hand showed a strong correlation (*R*^2^ = 0.711, *p* \< 0.01). This relation (R~1b~ = 0.80 × Hct~ad~ + 0.22) was within the error margins of the relationship found by Lu et al. in venous blood (R~1b~ = 0.83 × Hct + 0.28) ([@ref20]). The relationship deviates somehow from the one reported by [@ref35]), although our 95% confidence interval also encompasses their solution. Again, a plausible explanation could be attributed to differences in oxygenation levels in the sagittal sinus. While Lu et al. maintained a constant oxygen saturation (69%) in an in-vitro experiment on bovine blood ([@ref20]), then neither the current study nor the one of [@ref35]) controlled for venous oxygenation. Nevertheless, our results do suggest that the neonatal *T*~1b~ can be derived from arterial-drawn haematocrit measured by means of a point-of-care device. Despite this, one should always be careful that the haematocrit measurements are not influenced by hypoproteinaemia ([@ref1]), hyperlipidaemia ([@ref30]) or drugs ([@ref39]). As we did not have information about the drugs administered to the neonates we could not investigate the impact of drugs on haematocrit and consequently the haematocrit--*T*~1b~ relation.

There are some limitations to this study. First, as mentioned above, we did not take into account the effect of venous oxygenation on our *T*~1b~ values although simulations demonstrate that venous oxygenation can have an effect on the *T*~1b~. This may explain why the relation between haematocrit and the *T*~1b~ was not as strong as previously published relations. In this regard we should mention that the *T*~1b~ expected for ASL CBF quantification is the arterial *T*~1b~ while we measured the venous. It is hard to do a correction for this without knowledge of the actual venous blood oxygenation and the haematocrit, although at 3 T and at typical venous oxygenation levels the *T*~1b~ is approximately 100 ms shorter than the arterial *T*~1b~ ([@ref20]; [@ref33]) which is also illustrated in [Fig. 3a](#gr3){ref-type="fig"}. The reasons for not measuring arterial blood directly are manifold. In the neonates the blood vessels are very small and even within the sagittal sinus, targeted in this study, only 5 voxels could be used on average. The feeding arterial vessels are even smaller making partial volume and small scale motion a problem. In addition the higher blood velocities and highly pulsatile flow complicate accurate acquisition and subsequent *T*~1~ quantification. While not a problem in neonates, then older children and adults extend outside the transmit coil, contaminating the inversion recovering arterial blood with fresh fully relaxed blood.

In addition, we investigated the influence of haematocrit on the *T*~1b~ and how it influenced the brain--blood partition coefficient (λ) which is also used for quantification. We demonstrated that the normalized perfusion difference introduced by the effect of haematocrit on λ is minor compared to the normalized perfusion difference caused by the *T*~1b~ assumption. It should be mentioned that λ does not only depend on the neonates\' haematocrit but also on the brains\' water content which is known to decrease after birth ([@ref5]; [@ref19]) and this was not taken into account in our simulations. However, there are some other factors which potentially could have affected the CBF differences in between groups and which may affect the CBF during longitudinal follow-up. The most important one would be the label bolus arrival time which potentially could be dependent on postnatal age. In this study we used a Q~2~TIPS scheme which ensures a well-defined bolus length and thereby makes the CBF estimate less sensitive to differences in arrival time ([@ref23]). Nevertheless, little is known about the validity of the assumptions made during quantification in the neonates, the main reason being the fact that typically very little time is allocated to experimental scans before sedation wears out. Future studies should investigate if for instance the generated bolus fulfils the requirement of being longer than *TI*~1~, and how big an error is introduced by assuming no exchange and ignoring the arterial transit time (*q* = 1 in Eq. (2) of [@ref23]. A general problem with ASL in neonates is the poor signal to noise in the perfusion maps and this is regardless of the generally longer *T*~1~ of blood observed in neonates compared to adults. The longer *T*~1~ of blood would result in a longer lasting label bolus, however, due to the intrinsic low perfusion in neonates and the fact that motion can be a problem, the signal to noise remains low. Hardware improvements and optimization of e.g. pseudocontinuous ASL for the neonates may improve the situation, however, good strategies for efficient dealing with motion may be even more beneficial in this patient population. For instance, the potential benefits of high signal-to-noise 3D readout strategies with subsequent image registration and prospective motion correction schemes should be investigated in the future.

Lastly, as our scans were performed at the end of a clinical imaging protocol, when sedation started to wear of, we experienced motion issues. This was reflected in an unsuccessful fitting of the *T*~1b~ in 32% of the neonates primarily caused due to excessive image noise or patient motion resulting in a non-converging fit. In other instances it was impossible to detect a region of interest in the sagittal sinus region.

In conclusion, we confirmed the wide variability of *T*~1b~ in neonates and demonstrated differences between preterms and preterms at term-equivalent age related to changes in haematocrit. This study suggests that the *T*~1b~ should be corrected when performing blood-*T*~1~ dependent MRI studies in neonates such as ASL perfusion imaging. The relation between arterial-drawn haematocrit, measured with a point-of-care device, and the *T*~1b~ was similar to the earlier described one which relied on spinning or sedimentation techniques to determine the haematocrit. Therefore, the *T*~1b~ derived from arterial-drawn haematocrit as measured by a point-of-care device can be a good approach to estimate the *T*~1b~ in neonates until established *T*~1b~-sequences are standard on the scanners. However we also showed that capillary-drawn Hct values have limited value and should be avoided when inferring blood *T*~1~ from haematocrit. In neonates without an arterial-drawn blood sample one can always choose to use a more appropriate neonatal *T*~1b~ value to minimize the normalized perfusion difference. For instance 1.85 s which was the mean *T*~1b~ value found in our population or a preterm or term-equivalent values as reported in [Table 3](#tbl3){ref-type="table"}, if applicable.
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![a) MR sequence chart of the *T*~1~ inversion recovery sequence. The *T*~1~ inversion recovery sequence consisted of a presaturation pulse followed by an adiabatic inversion pulse and a single-shot echo-planar imaging as readout. b--d) Data of a preterm born female infant with MR imaging at term-equivalent age, the postconceptional age of this infant at birth was 26 weeks and MR imaging was performed at 41 weeks. b) Example plot of the acquired data, obtained in the final ROI (which was composed of 5 voxels) within the sagittal sinus, and its corresponding fit. c) Repeated acquisition at a high flip angle ensures saturation of brain tissue and allows for only inflowing blood to be imaged. An automatic localizer tool (red dot) localizes the sagittal sinus based on signal intensity. d) Example of a quantitative arterial spin labelling image.](gr1){#gr1}

![a) Median, interquartile range, minimum and maximum *T*~1b~ values (in seconds) for each category; preterms, preterm born infants imaged at term-equivalent age (TEA), and diseased infants which were the infants with a clinical indication for MR imaging. b) The relation between postnatal age (PNA, in days) and the *T*~1b~ (in seconds) is shown; each category of infants (preterms, TEA and diseased) is shown in a different colour.](gr2){#gr2}

![a) A scatter plot demonstrating the relation between haematocrit (Hct) and MRI-derived *T*~1b~ (in seconds). b) A scatter plot demonstrating the relation between arterial-drawn haematocrit (Hct~ad~) and MRI_derived *T*~1b~ (in seconds). c) A scatter plot demonstrating the relation between capillary-drawn haematocrit (Hct~cd~) and MRI-derived *T*~1b~ (in seconds).](gr3){#gr3}

![a) Dependence of the *T*~1b~ on haematocrit (Hct) and oxygenation (Y). b) Simulation demonstrating the normalized perfusion difference introduced by the influence of haematocrit (Hct) on the *T*~1b~, with (full line) and without (dotted line) taking the influence of haematocrit on the brain--blood partition coefficient (λ) into account.](gr4){#gr4}

###### 

Subject characteristics.

  -----------------------------------------------------------------------------------
  Group      N    PCA~b~\       PNA\           Gender       Breathing
                  (weeks)       (days)                      
  ---------- ---- ------------- -------------- ------------ -------------------------
  Preterm    18   28 (24--34)   25 (7--42)     7 M--11 F    SIMV: 3 infants\
                                                            CPAP: 10 infants\
                                                            BiPAP: 2 infants\
                                                            Independent: 3 infants

  TEA        50   28 (24--34)   89 (36--119)   24 M--26 F   Independent: 50 infants

  Diseased   52   39 (33--42)   20 (1--103)    28 M--24 F   SIMV: 16 infants\
                                                            CPAP: 3 infants\
                                                            Independent: 33 infants
  -----------------------------------------------------------------------------------

PCA~b~, postconceptional age at birth; PNA, postnatal age when MR imaging was performed; TEA, term-equivalent age; M, male; F, female; SIMV, synchronized intermittent mandatory ventilation; CPAP, continuous positive airway pressure; BiPAP, bilevel positive airway pressure.

PCA~b~, mean (range) PNA, the number of male and female infants and their breathing condition at the time of MR imaging for each category of neonates; preterm, TEA: preterm born infants with MR imaging at TEA, diseased: infants with a clinical indication for MR imaging.

###### 

*T*~1~ of blood in categories of neonates.

             *T*~1~ of blood                              
  ---------- ----------------- ------------- ------------ -------------
  Preterm    11                1.77 (0.14)   1.42--1.90   −3.21, 3.13
  TEA        43                1.89 (0.19)   1.51--2.30   −2.14, 2.28
  Diseased   28                1.81 (0.24)   1.46--2.35   −2.06, 2.03

This table shows the mean (standard deviation, sd), the range and the 95% confidence interval (95% CI) of the *T*~1b~ within each category of infants; preterm, TEA: preterm born infants with MR imaging at term-equivalent age, diseased: infants with a clinical indication for MR imaging.

###### 

Cerebral blood flow values in each category.

  ---------------------------------------------------------------------------------------------------------------
  Group      *N*          CBF~1.6~\        CBF~1.85~\       CBF~cor~\        NPD\              NPD\
                          (ml/100 g/min)   (ml/100 g/min)   (ml/100 g/min)   (CBF~cor--1.6~)   (CBF~cor--1.85~)
  ---------- ------------ ---------------- ---------------- ---------------- ----------------- ------------------
  Preterm    3 M--6 F     8.5 (6.1)        7.4 (5.3)        8.1 (6.2)        −7 (8.6)%         6.4 (9.9)%

  TEA        18 M--23 F   16.6 (7)         14.5 (6.1)       14.4 (6.1)       −13.3 (7.7)%      −0.8 (8.8)%

  Diseased   13 M--13 F   21.5 (14.7)      18.8 (12.9)      19.7 (14.5)      −8.6 (10.5)%      4.6 (12)%
  ---------------------------------------------------------------------------------------------------------------

In this table mean whole brain perfusion values obtained when quantifying the ASL images with a *T*~1b~ of 1.6 s (CBF~1.6~), with a *T*~1b~ of 1.85 s (CBF~1.85~), and with the corrected *T*~1b~ (CBF~cor~) are shown for each category; preterm. TEA: preterm born infants with MR imaging at term-equivalent age, diseased: infants with a clinical indication for MR imaging. The number of subjects per category is shown in the column with the heading 'N' with M as the number of male subjects and F as the number of female subjects. The mean (standard deviation) normalized perfusion difference when going from CBF~1.6~ to CBF~cor~ (CBF~cor--1.6~) is shown and the mean (standard deviation) normalized perfusion difference when going from CBF~1.85~ to CBF~cor~ (CBF~cor--1.85~) is shown. The normalized perfusion difference, when going from CBF~1.6~ to CBF~cor~, was significantly different in preterm than in the TEA (*p* \< 0.05).
